Interestingly, MELK activity together with FOXM1 has been shown to positively regulate both SOX2 and EZH2 in other tumours, such as glioma and medulloblastoma (Ganguly et al, 2014; Kim et al, 2015; Liu et al, 2017). Here, SOX2 is linked to central nervous system cancer.